This Biotech’s Stock Soaring After FDA Official Exits
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
Blue chip cryptos offer resilience, liquidity, and potential for steady growth. Learn the main reasons to consider them as a foundational holding.
19,600 articlesBiotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
Investors often wonder if a smaller company can replicate Berkshire Hathaway’s long-term success. This analysis looks...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Loopring has halted trading on its decentralized exchange, citing outdated zkRollup tech and a strategic pivot toward...
The nobel laureate joseph stiglitz warns that AI’s hunger for internet chatter could degrade the data powering market...
As housing markets tighten, brokerages race to deploy must-have real estate marketing tools in 2026. This story break...
A Senate staff brief on the ROAD to Housing Act flags design flaws and local zoning reliance, signaling lenders and b...
Palo Alto Networks leads a broad cybersecurity rally as UBS projects a multibillion-dollar market by 2026, sparking c...
Mastercard launches a digital, AI-powered Virtual CFO to deliver CFO-grade guidance to small businesses, addressing a...
Nuvation Bio has surged, even as an insider sold a meaningful stake. This piece breaks down what the move means, how ...
In February, the Mortgage Credit Availability Index rose 1.1% to 107.1, signaling looser lending in conventional prog...
Anthropic faces a high-stakes regulatory battle in Washington that could redefine how AI startups grow and attract mo...